overus
antibiot
last
sever
decad
preval
antibioticresist
bacteri
infect
present
threat
global
health
million
peopl
project
kill
antibioticresist
bacteria
therefor
discoveri
novel
antibiot
agent
increas
medic
import
howev
also
potenti
overus
abus
new
antibiot
give
rise
antibioticresist
bacteria
grow
difficulti
discoveri
new
antibiot
clinic
use
divert
attent
new
therapeut
agent
antimicrobi
peptid
amp
altern
approach
prevent
spread
bacteria
resist
antibiot
antimicrobi
peptid
amp
extens
studi
sinc
broad
spectrum
antiinfect
activ
pathogen
bacteria
rel
low
minim
inhibitori
concentr
properti
less
capabl
incur
resist
convent
antibiot
due
nonspecif
interact
bacteri
membran
abil
work
multipl
target
addit
direct
antimicrobi
activ
mani
amp
associ
immunomodulatori
properti
seen
hostdefens
peptid
meet
demand
amp
clinic
applic
produciton
amp
achiev
chemic
synthesi
exampl
phase
peptid
synthesi
approach
provid
easi
isol
peptid
high
puriti
less
use
solvent
avoid
chromatograph
purif
howev
chemic
synthesi
sever
disadvantag
prevent
costeffect
industrialscal
product
amp
addit
synthesi
longer
peptid
amino
acid
favor
high
product
larg
peptid
biolog
system
bacteria
yeast
prefer
use
product
platform
although
biolog
system
need
expens
activ
pharmaceut
ingredi
api
toxic
chemic
solvent
still
issu
remain
toxic
express
amp
host
cell
expens
purif
low
yield
solut
address
issu
plant
viabl
altern
express
platform
addit
use
deliveri
platform
well
report
new
vector
system
product
amp
express
amp
bacteria
plant
vector
design
oper
prokaryot
system
use
transform
chloroplast
prokaryot
organel
plant
larg
scale
product
amp
plant
express
system
offer
sever
advantag
microbi
express
system
includ
risk
endotoxin
contamin
oral
deliveri
bioencapsul
therapeut
use
edibl
plant
express
cassett
vector
design
surround
flank
sequenc
allow
cassett
integr
chloroplast
genom
via
doubl
homolog
recombin
moreov
copi
number
transgen
chloroplast
multipli
per
singl
plant
cell
lead
high
express
transgen
addit
vector
design
amp
express
fuse
form
use
tag
sumo
order
elimin
toxic
amp
prokaryot
host
prevent
proteas
degrad
increas
solubl
simplifi
purif
detect
howev
tag
need
remov
prior
clinic
use
final
product
need
authent
nativ
amino
acid
sequenc
cleavag
recognit
site
place
therapeut
peptid
tag
howev
remov
tag
protein
cleavag
site
often
steric
hinder
cleavag
action
proteas
factor
xa
enterokinas
thrombin
tobacco
etch
viru
proteas
often
nonspecif
unlik
proteas
recogn
linear
amino
acid
sequenc
sumo
proteas
sumoas
recogn
tertiari
structur
sumo
prevent
erron
cleavag
event
target
protein
evalu
express
platform
amp
e
coli
abaecin
honeybe
api
mellifera
express
use
new
vector
system
abaecin
import
peptid
bee
innat
immun
system
found
varieti
bee
includ
api
mellifera
bombu
pascuorum
bombu
ignitu
prolinerich
nonglycosyl
antimicrobi
peptid
abaecin
broad
spectrum
bacteriolyt
activ
show
increas
inhibitori
effect
bacteri
growth
treat
poreform
peptid
cecropin
stomoxyn
hymenoptaecin
cation
peptid
contain
prolin
cystein
residu
uniform
distribut
prolin
residu
entir
peptid
prevent
conform
describ
new
express
platform
effici
produciton
amp
potenti
oper
bacteria
plant
chloroplast
use
express
platform
ecoli
first
test
studi
new
express
vector
built
backbon
vector
assembl
compon
dna
fragment
utr
utr
flank
sequenc
deriv
plant
chloroplast
bacteri
gene
equip
tag
system
sumo
new
express
vector
design
use
prokaryot
system
bacteria
plant
chloroplast
psba
utr
utr
employ
drive
high
express
transgen
stabil
express
transcript
respect
fig
second
express
cassett
counteract
spectinomycin
construct
select
transform
cell
antibiot
resist
gene
aada
put
control
rrna
promot
transcript
stabil
use
utr
fragment
ecoli
rrnb
operon
chloroplast
express
transgen
flank
sequenc
integr
express
cassett
chloroplast
genom
specif
locat
ad
end
combin
express
cassett
fragment
flank
sequenc
deriv
trni
trna
region
tobacco
chloroplast
genom
integr
region
transcript
activ
wide
use
high
express
transgen
dna
element
amplifi
pcr
synthes
combin
backbon
vector
construct
new
vector
fig
b
vector
modifi
addit
tag
system
sumo
deriv
human
attach
abaecin
increas
solubl
prevent
toxic
abaecin
host
cell
also
purif
tag
ad
nterminu
sumo
facilit
purif
sumofus
abaecin
isol
abaecin
sumo
cleavag
sumoas
three
differ
combin
codonoptim
synthet
sequenc
clone
new
vector
express
e
coli
system
investig
confirm
sequenc
fig
b
addit
file
figur
codon
optim
codon
adjust
perform
accord
previou
studi
new
algorithm
codon
optim
develop
base
codon
usag
hierarchi
chloroplast
psba
gene
codonoptim
sequenc
control
utr
show
increas
express
level
respect
nativ
sequenc
e
coli
plant
chloroplast
express
three
fusion
construct
show
toxic
host
cell
shown
fig
signific
differ
optic
densiti
od
valu
untransform
transform
cell
three
fusion
construct
grown
overnight
three
construct
fusion
protein
evalu
use
e
coli
express
system
transform
e
coli
cell
three
construct
grown
liquid
cultur
rel
express
level
three
fusion
protein
examin
use
immunoblot
assay
antihi
antibodi
express
fusion
protein
detect
around
kda
kda
deduc
molecular
weight
fig
kind
discrep
often
observ
prolinerich
protein
express
e
coli
due
presum
increas
rigid
caus
high
prolin
content
lead
slower
migrat
molecular
weight
protein
abaecin
kda
amino
acid
contain
prolin
total
amino
acid
account
assum
high
content
prolin
residu
affect
migrat
three
fusion
protein
amino
acid
length
construct
among
three
fusion
protein
n
abaecin
c
n
c
stand
nativ
sequenc
codonoptim
sequenc
respect
show
highest
express
fold
higher
express
c
abaecin
n
c
abaecin
c
respect
fig
three
construct
show
express
fusion
protein
detect
level
time
higher
solubl
fraction
insolubl
one
fig
data
confirm
newli
design
vector
oper
prokaryot
system
nativ
sequenc
heterolog
human
sumo
gene
improv
express
sumofus
abaecin
e
coli
fig
cleavag
effici
sumoas
fusion
protein
investig
treat
solubl
protein
extract
e
coli
sumoas
h
detect
treat
protein
coomassi
stain
western
blot
seen
fig
fusion
protein
detect
kda
treatment
sumoas
cleav
produc
two
product
fig
confirm
result
immunoblot
assay
replic
gel
perform
use
antihi
antibodi
band
cleavedoff
domain
detect
around
kda
along
band
fusion
protein
around
kda
fig
data
confirm
tertiari
structur
sumo
correctli
form
e
coli
recogn
sumoas
fig
confirm
proper
express
cleavag
sumo
tag
fig
fusion
protein
purifi
mass
analysi
abaecin
cleav
fusion
protein
fig
abaecin
cleav
sumoas
examin
malditof
analysi
verifi
precis
cleavag
sumo
abaecin
singli
proton
molecular
ion
h
cleavedoff
abaecin
observ
mz
da
use
reflector
mode
fig
theoret
molecular
mass
da
fig
discrep
observ
theoret
valu
suggest
possibl
delet
abaecin
peptid
either
n
c
termini
identifi
peptid
peak
calcul
mass
seri
delet
abaecin
peptid
either
n
ctermini
compar
theoret
mass
observ
mass
fig
best
amino
acid
sequenc
correspond
observ
mass
da
deduc
yvplpnvpqpgrrpfptfpgqgpfnpkik
indic
delet
amino
acid
cterminu
abaecin
fig
base
result
although
proper
cleavag
sumo
abaecin
occur
undesir
cleavag
happen
cterminu
sinc
small
cation
peptid
suscept
proteolyt
degrad
ecoli
posit
charg
distribut
abaecin
analyz
fig
posit
charg
patch
creat
two
ly
k
residu
cterminu
like
target
proteolyt
attack
next
analyz
whether
abaecin
still
retain
function
bind
sequenc
intracellular
target
molecul
dnak
analysi
use
limbo
server
http
limboswitchlaborg
found
shorter
form
abaecin
still
bind
sequenc
dnak
yvplpnv
number
score
fig
therefor
continu
test
antimicrobi
activ
abaecin
deriv
without
cecropin
b
bacillu
subtili
evalu
antimicrobi
activ
abaecin
express
e
coli
activ
test
b
subtili
use
agar
diffus
assay
purifi
abaecin
deriv
also
test
whether
sumofus
abaecin
toxic
bacteria
treat
extern
although
alreadi
confirm
toxic
abaecin
host
cell
express
cell
fig
treatment
show
bacteriolyt
activ
b
subtili
fig
b
preliminari
test
found
antib
subtili
activ
abaecin
requir
amount
fig
b
antimicrobi
activ
abaecin
enhanc
combin
treatment
cecropin
b
antimicrobi
activ
observ
cecropin
b
peptid
treat
fig
b
howev
antimicrobi
activ
abaecin
dose
increas
combin
cecropin
b
fig
b
antibacteri
activ
abaecin
enhanc
increas
cecropin
b
quantiti
fig
b
result
consist
previou
report
function
interact
abaecin
poreform
peptid
cecropin
stomoxyn
hymenoptaecin
subleth
concentr
reciproc
potenti
bacteriolyt
activ
increas
membran
permeabil
taken
togeth
abaecin
express
solubl
form
e
coli
caus
toxic
host
cell
tag
properli
recogn
remov
sumoas
cleav
abaecin
long
size
long
howev
purifi
abaecin
retain
antimicrobi
activ
activ
potenti
cotreat
poreform
antimicrobi
peptid
cecropin
b
limit
convent
antibiot
treat
pathogen
microb
increas
preval
antibioticresist
pathogen
led
explor
viabl
altern
includ
antimicrobi
peptid
limit
number
antibiot
avail
clinic
use
similar
activ
spectrum
action
mode
amp
distinct
advantag
antibiot
remark
structur
function
divers
immunomodulatori
activ
amp
show
broad
rang
action
effect
use
treat
multimicrobi
infect
includ
gramposit
gramneg
bacteria
current
antibiot
peptid
avail
clinic
use
howev
number
amp
clinic
trial
develop
applic
limit
directli
kill
pathogen
eg
pexiganan
treatment
bacteri
infect
diabet
foot
ulcer
omiganan
cathet
infect
rosacea
bacteri
fungal
infect
immunocompromis
stem
cell
transplant
novexatin
fungal
infect
vagin
candidiasi
wound
heal
prevent
postsurg
adhes
formul
iseganan
oral
mucos
oral
candidiasi
despit
potenti
develop
avail
amp
clinic
use
met
sever
challeng
primarili
high
product
cost
low
scalabl
chemic
peptid
synthesi
prevent
widespread
develop
adopt
amp
viabl
clinic
treatment
biolog
product
use
recombin
prokaryot
system
viabl
altern
chemic
synthesi
issu
toxic
host
cell
degrad
product
proteas
low
yield
must
address
studi
sumo
tag
system
use
prevent
toxic
express
antimicrobi
peptid
host
cell
commonli
use
fusion
carrier
thioredoxin
kda
glutathionestransferas
gst
kda
sever
advantag
associ
increas
solubl
promot
proper
fold
prevent
toxic
amp
howev
gst
increas
rel
molecular
weight
ratio
carrier
protein
peptid
lead
low
amp
yield
also
sever
gst
fusedamp
express
ecoli
show
proteolyt
activ
result
ineffici
fail
amp
product
thioredoxin
favor
use
peptid
product
gst
due
small
size
allow
high
peptid
yield
attribut
high
peptidetocarri
ratio
howev
proteas
use
releas
attach
peptid
carrier
expens
sensit
ph
chaotrop
compar
sumo
proteas
moreov
amp
tag
aggregationpromot
carrier
purf
fragment
ketosteroid
isomeras
shown
toxic
host
bacteri
cell
sumo
tag
mani
similar
advantag
thioredoxin
orand
gst
system
includ
high
yield
result
high
ratio
peptidetotag
protein
enhanc
solubl
toxic
host
cell
also
uniqu
advantag
tag
sumoas
recogn
tertiari
structur
sumo
cleav
substrat
attach
unwant
amino
acid
peptid
precis
cleavag
target
protein
sumo
fusion
sumoas
confirm
compar
molecular
mass
ntermin
amino
acid
sequenc
releas
peptid
correspond
synthet
peptid
use
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
edman
degrad
detail
inform
current
tag
express
system
product
antimicrobi
peptid
ecoli
includ
addit
file
tabl
studi
confirm
proper
cleavag
abaecin
sumo
use
malditof
ctermin
delet
abaecin
contrast
expect
attach
sumo
tag
overal
charg
protect
abaecin
overal
charg
fig
via
electrostat
interact
endogen
proteas
ecoli
system
small
size
peptid
high
cation
content
highli
suscept
proteolyt
attack
ecoli
shown
pier
et
al
studi
studi
direct
express
small
size
cation
peptid
human
neutrophil
peptid
kind
defensin
success
transcript
detect
even
cation
peptid
synthet
cecropinmelittin
hybrid
ceme
fuse
gst
fusion
protein
proteolyz
howev
proteolysi
observ
anion
prepro
defensin
sequenc
insert
gst
cation
peptid
base
analysi
posit
charg
patch
creat
two
arg
r
posit
fig
seem
recogn
endogen
proteas
possibl
due
charg
neutral
effect
electrostat
interact
sumo
second
patch
creat
two
ly
k
posit
fig
seem
subject
proteolyt
attack
anoth
possibl
ctermin
delet
could
consequ
excess
sonic
result
denatur
fusion
protein
breakdown
cterminu
also
rule
sumoas
could
aberrantli
cleav
abaecin
thought
sumoas
highli
specif
activ
broad
rang
condit
cleav
effect
wide
rang
ph
temperatur
even
deterg
urea
mm
dtt
howev
cleavag
studi
junction
sumo
partner
protein
show
cleavag
work
first
amino
acid
partner
protein
pro
p
also
introduct
stretch
sever
tri
w
residu
close
cleavag
site
caus
random
cleavag
within
fusion
protein
due
inaccess
sumoas
steric
hindranc
howev
reliev
addit
urea
led
releas
correct
size
peptid
consid
high
content
prolin
abaecin
repeat
kink
gener
prolin
abaecin
could
creat
steric
hindranc
attach
sumo
would
lead
unexpect
random
cleavag
investig
issu
mention
sumo
could
modifi
way
introduc
addit
glycin
resid
cleavag
junction
releas
steric
hindranc
unpublish
studi
cleavag
sumocecropin
b
junction
sumoas
happen
introduct
addit
glycin
residu
also
genet
modifi
sumo
neg
charg
could
provid
better
protect
cation
peptid
although
cterminu
abaecin
sustain
delet
sumoas
cleavag
abaecin
show
antimicrobi
activ
b
subtili
function
studi
sumoabaecin
fusion
protein
bacteriolyt
activ
shown
fig
furthermor
bacteriolyt
activ
consist
previou
report
antimicrobi
activ
abaecin
alon
enhanc
combinatori
treatment
poreform
amp
although
abaecin
high
bind
efficaci
dnak
like
prolinerich
dnakbind
amp
includ
metalnikowin
metchnikowin
onocin
apidaecin
drosocin
pyrrhocoricin
abaecin
conserv
motif
yliprp
analyz
abaecin
amino
acid
sequenc
abaecin
function
bind
sequenc
dnak
use
limbo
server
found
full
length
abaecin
two
bind
sequenc
site
one
nterminu
score
one
cterminu
score
assum
reason
long
abaecin
still
antimicrobi
activ
fig
due
presenc
ntermin
bind
sequenc
dnak
fig
main
purpos
studi
introduc
new
express
platform
product
antimicrobi
peptid
ecoli
system
way
harm
host
cell
abaecin
chosen
refer
amp
target
intracellular
molecul
dnak
prokaryot
heat
shock
protein
bind
abaecin
dnak
caus
protein
metabol
compromis
e
coli
result
host
cell
death
fusion
protein
howev
exhibit
toxic
e
coli
host
cell
transform
e
coli
cell
grew
liquid
cultur
similar
growth
rate
untransform
one
fig
furthermor
purifi
fusion
protein
show
antibactericid
activ
b
subtili
fig
b
normal
growth
transform
e
coli
lack
antimicrobi
activ
fusion
protein
b
subtili
prove
lethal
activ
amp
host
cell
properli
shield
sumo
activ
restor
releas
tag
antimicrobi
activ
amp
gener
determin
hydrophob
net
posit
charg
report
previou
studi
electrostat
interact
posit
charg
amp
neg
charg
residu
within
sumo
overal
charg
seem
play
key
role
neutral
bacteriolyt
activ
protect
amp
degrad
endogen
proteas
regard
although
protect
abaecin
proteolyt
degrad
sumo
fail
ctermin
delet
abaecin
still
antimicrobi
activ
furthermor
toxic
abaecin
way
success
prevent
sumo
tag
via
presum
electrostat
interact
sumo
tag
system
also
advantag
disulfid
bond
due
reduc
environ
e
coli
cytoplasm
protein
requir
disulfid
bond
fail
achiev
activ
form
ultim
form
inclus
bodi
degrad
proteas
achiev
maintain
activ
form
protein
need
redirect
periplasm
space
secret
energyconsum
could
potenti
lower
target
protein
yield
howev
sumo
tag
system
requir
addit
step
contain
one
cystein
entir
amino
acid
sequenc
overal
sumoabaecin
fusion
protein
detect
solubl
fraction
insolubl
one
fig
b
toxic
host
cell
mani
report
sumo
fusion
increas
solubl
difficulttoexpress
protein
ecoli
gfp
metalloproteas
sever
acut
respiratori
syndrom
coronaviru
sar
cov
protein
includ
proteas
nucleocapsid
protein
spike
c
protein
howev
contrast
antimicrobi
peptid
protein
toxic
host
cell
conclus
distinguish
effect
sumo
solubl
fusion
protein
express
abaecin
alon
would
need
compar
sumoabaecin
fusion
protein
howev
examin
studi
due
technic
issu
possibl
low
stabil
potenti
toxic
host
cell
mention
direct
express
small
size
high
cation
content
amp
highli
suscept
endogen
proteolysi
furthermor
express
abaecin
alon
could
lethal
host
cell
peptid
inhibit
intracellular
dnak
central
organ
chaperon
network
ecoli
chaperon
protein
interact
cytosol
protein
among
protein
rel
prone
aggreg
reli
extens
dnak
initi
fold
translat
effici
codonoptim
heterolog
sequenc
evalu
studi
partial
whole
optim
order
find
accommod
nucleotid
sequenc
ecoli
system
codon
usag
adjust
accord
codon
usag
prefer
gene
psba
highli
express
prokaryot
system
three
differ
combin
codonoptimz
sequenc
creat
codon
adjust
perform
way
increas
compat
utr
psba
promot
code
region
fusion
gene
increas
content
sumo
sequenc
contrast
expect
codon
optim
ntermin
sumo
fusion
protein
fail
improv
express
level
nonoptim
counterpart
seen
fig
b
nativ
sequenc
sumo
perform
better
correspond
codonoptim
sequenc
express
fusion
protein
express
level
nativ
codonoptim
time
higher
codonoptim
nativ
codonoptim
codonoptim
respect
fig
like
due
stabil
transcrib
mrna
nativ
sumo
sequenc
may
rel
higher
stabil
codonoptim
sequenc
anoth
possibl
explan
compat
utr
promot
code
sequenc
codonoptim
sumo
could
compromis
result
unstabl
ineffici
translat
initi
complex
gener
thought
translat
effici
influenc
effici
format
translat
initi
complex
thu
first
codon
consid
import
rest
sequenc
therefor
margin
differ
express
level
codonoptim
sumo
fuse
nativ
codonoptim
abaecin
could
conseqeunc
ineffici
format
translat
initi
complex
recent
studi
found
reciproc
function
interact
abaecin
poreform
peptid
occur
peptid
coexpress
speci
one
speci
pore
creat
membran
poreform
peptid
allow
abaecin
access
intracellular
target
dnak
inhibit
heat
shock
protein
compromis
protein
metabol
damag
pore
remain
unrepair
thu
allow
abaecin
even
greater
access
target
abaecin
abil
increas
membran
permeabil
consequ
reduc
minim
inhibitori
concentr
abaecin
poreform
peptid
reciproc
manner
likewis
activ
poreform
peptid
cecropin
b
hyalophora
cecropia
potenti
combinatori
treatment
abaecin
fig
show
abaecin
use
divers
poreform
peptid
inhibit
bacteria
renit
convent
antibiot
one
challeng
applic
amp
present
demand
effect
patientfriendli
deliveri
system
particularli
patient
chronic
diseas
current
amp
clinic
develop
design
target
local
infect
use
topic
formul
amp
develop
system
deliveri
although
oral
deliveri
system
like
prefer
due
straightforward
administr
amp
requir
special
consider
peptid
rapidli
broken
gastrointestin
tract
due
high
concentr
proteas
high
acid
respect
edibl
plant
use
deliveri
platform
peptid
base
drug
bioencapsul
within
plant
cell
protect
harsh
environ
gastrointestin
tract
drug
releas
intestin
breakdown
cell
wall
cellulolyt
bacteria
plant
express
deliveri
system
also
elimin
concern
endotoxin
contamin
caus
fatal
septic
shock
recipi
furthermor
oral
deliveri
peptid
edibl
plant
cell
elimin
need
expens
downstream
purif
reduc
product
cost
benefit
patient
futur
studi
evalu
efficaci
plant
express
system
well
sumo
tag
express
system
show
applic
method
product
amp
e
coli
although
could
nt
complet
protect
abaecin
test
studi
endogen
proteolyt
degrad
increas
solubl
prevent
toxic
abaecin
host
cell
furthermor
releas
amp
sumo
tag
retain
antimicrobi
activ
show
enhanc
antimicrobi
effect
combinatori
applic
poreform
peptid
therefor
studi
enhanc
stabil
translat
effici
sumofus
amp
make
use
amp
afford
clinic
patient
recombin
proteinpeptid
code
sequenc
dna
element
design
referenc
deposit
sequenc
nation
center
biotechnolog
inform
ncbi
previou
report
genbank
access
number
sequenc
follow
abaecin
sumo
cecropin
b
codonoptim
nucleotid
sequenc
abaecin
sumo
nativ
sequenc
aada
trrnb
deduc
previou
report
synthes
macrogen
south
korea
sequenc
utr
tpsba
deduc
previou
report
amplifi
use
tobacco
chloroplast
genom
dna
templat
pcr
codon
optim
perform
accord
previou
studi
primer
use
pcr
amplif
ppsba
tpsba
trna
trni
dna
fragment
follow
ppsbaf
ppsbar
tpsbaf
tpsbar
trnaf
trnar
trnif
trnir
ppsbatpsba
dna
fragment
amplifi
overlap
pcr
treat
asei
sali
insert
backbon
plasmid
restrict
ndei
sali
ligat
plasmid
digest
bamhi
ecori
dna
fragment
synthes
macrogen
digest
bamhi
ecori
ligat
intermedi
vector
vector
contain
combin
trni
dna
fragment
use
hindiii
sali
trna
fragment
insert
use
kpni
ecori
newli
construct
vector
use
express
recombin
fusion
gene
insert
vector
xbai
ndei
e
coli
transform
grown
l
terrif
broth
sigmaaldrich
usa
contain
ampicillin
spectinomycin
h
speed
rpm
overnight
cultur
grown
overnight
cell
collect
centrifug
rpm
min
resuspend
ml
buffer
includ
mm
tri
mm
sodium
chlorid
mm
imidazol
cell
sonic
cycl
sonic
usa
solubl
insolubl
fraction
separ
use
centrifug
rpm
h
quantifi
use
bradford
sigmaaldrich
usa
quantifi
protein
sampl
mix
laemmli
sampl
buffer
biorad
usa
heat
min
heat
protein
run
sdspage
separ
protein
blot
onto
pvdf
membran
membran
block
tbst
tween
skim
milk
h
room
temperatur
antihi
antibodi
santa
cruz
usa
dilut
block
solut
incub
h
membran
wash
tbst
buffer
min
thrice
secondari
antibodi
goat
antirabbit
igghrp
santa
cruz
usa
dilut
block
solut
incub
room
temperatur
h
wash
membran
subject
ecl
buffer
develop
use
cdigit
blot
scanner
licor
usa
e
coli
transform
grown
treat
describ
sonic
supernat
filter
filter
paper
advantec
japan
syring
filter
minisart
syring
filter
sartoriu
stedim
biotech
germani
filtrat
incub
ni
suferflow
resin
takara
japan
invert
slowli
h
bind
incub
column
wash
column
volum
wash
buffer
mm
tri
mm
sodium
chlorid
mm
imidazol
ph
fusion
protein
bound
ni
resin
elut
approxim
column
volum
elut
buffer
mm
tri
mm
sodium
chlorid
mm
imidazol
ph
recombin
abaecin
isol
treatment
sumo
proteas
enzynom
south
korea
h
confirm
cleavag
sdspage
perform
use
bistri
gel
invitrogen
usa
me
buffer
ms
analysi
elut
sampl
appli
onto
anchorchip
target
bruker
daltonik
germani
use
acid
chca
sigma
matrix
accord
manufactur
recommend
ms
measur
perform
autoflex
ii
toftof
mass
spectrum
acquir
reflector
mode
use
chca
matrix
mass
analysi
carri
life
scienc
laboratori
co
http
wwwemasscokr
south
korea
agar
diffus
assay
perform
evalu
antimicrobi
activ
abaecin
one
hundr
microlit
b
subtili
liquid
cultur
overnight
plate
lb
agar
medium
punctur
use
tip
purifi
abaecin
drop
without
cecropin
b
express
purifi
way
describ
lab
plate
grown
h
zone
area
growth
b
subtili
inhibit
abaecin
measur
use
imagej
softwar
